Celldex Therapeutics buy Stifel Nicolaus
Start price
18.06.24
/
50%
€33.20
Target price
18.06.25
€54.03
Performance (%)
-45.18%
End price
19.06.25
€18.20
Summary
This prediction ended on 19.06.25 with a price of €18.20. Massive losses of -45.18% were the result for the BUY prediction by Stifel_Nicolaus. Stifel_Nicolaus has a follow-up prediction for Celldex Therapeutics where he still thinks Celldex Therapeutics is a Buy. Stifel_Nicolaus has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Celldex Therapeutics | 29.293% | 29.293% | 29.949% |
| iShares Core DAX® | -0,38 % | 1,09 % | 11,64 % |
| iShares Nasdaq 100 | -0,41 % | -1,97 % | 7,27 % |
| iShares Nikkei 225® | 1,84 % | 10,26 % | 31,38 % |
| iShares S&P 500 | -0,71 % | 0,44 % | 4,30 % |
Comments by Stifel_Nicolaus for this prediction
In the thread Celldex Therapeutics diskutieren
Celldex Therapeutics, Inc. (NASDAQ: CLDX) is now covered by analysts at Stifel Nicolaus. They set a "buy" rating and a $58.00 price target on the stock.
Ratings data for CLDX provided by MarketBeat
In the thread Trading Celldex Therapeutics
Die von Stifel_Nicolaus gewählte maximale Laufzeit wurde überschritten
Current prediction by Stifel_Nicolaus for Celldex Therapeutics
Celldex Therapeutics
Start price
Target price
Perf. (%)
€26.00
26.02.26
26.02.26
€57.53
26.02.27
26.02.27
-1.54%
27.02.26
27.02.26
